herv
retrovir
sequenc
integr
genom
evolut
known
repres
human
genom
recent
shown
compris
copi
retain
potenti
express
retrovir
protein
particl
abnorm
express
autoimmun
neurodegen
chronic
inflammatori
diseas
cancer
environment
factor
specif
viral
infect
shown
potent
activ
herv
tissuespecif
tempor
condit
sever
diseas
abnorm
activ
express
herv
protein
report
studi
recent
decad
led
proof
concept
herv
play
key
role
pathogenesi
ms
al
hervw
hervk
env
protein
induc
pathogen
effect
vitro
vivo
relev
pathognomon
featur
diseas
endogen
retrovirus
potenti
novel
therapeut
target
address
innov
therapeut
strategi
clinic
trial
human
genom
figur
detect
particularli
complex
may
explain
proport
within
genom
larg
underestim
data
evolv
technolog
improv
among
allow
sequenc
constitut
heterochromatin
region
long
remain
inaccess
two
type
transpos
element
distinguish
element
transpos
via
dna
intermedi
cutandpast
mechan
transposon
ii
use
rna
copypast
mechan
retrotransposon
retrotransposon
compris
endogen
retrovirus
erv
current
literatur
present
incomplet
data
well
sever
classif
nomenclatur
lead
ambigu
term
herv
refer
sequenc
human
erv
famili
herv
retain
structur
featur
retrovir
genom
figur
origin
enter
genom
speci
repeat
infect
germ
cell
million
year
figur
question
herv
copi
retain
code
potenti
may
becom
express
address
abil
herv
becom
activ
link
chromatin
state
given
copi
locat
dna
methyl
histon
modif
essenti
epigenet
control
human
gene
includ
herv
element
prerequisit
function
transcript
herv
sequenc
must
retain
function
long
termin
repeat
ltr
becom
control
anoth
promot
without
delet
nucleotid
substitut
disrupt
open
read
frame
orf
nuclear
microenviron
includ
chromatin
access
code
region
differ
tissu
baselin
predisposit
herv
copi
activ
tissu
cell
matur
stagespecif
inflammatori
stimuli
may
activ
herv
via
epigenet
dysregul
instanc
transcript
hervw
sequenc
report
upregul
proinflammatori
cytokin
cultur
cell
ms
patient
shown
correl
increas
differenti
peripher
blood
mononuclear
cell
ms
patient
contrast
box
infecti
origin
ms
suggest
first
time
pierr
mari
reject
contemporari
medic
commun
evid
virus
may
contribut
ms
come
accumul
immun
cell
within
brain
csf
local
immun
reactiv
specif
virus
presenc
oligoclon
band
ms
epidemiolog
indic
trigger
adolesc
unusu
geograph
distribut
gradient
latitud
except
eg
contrast
pattern
sardinia
japan
epidem
cluster
previous
isol
island
time
sever
virus
propos
caus
agent
ms
onward
includ
rabi
viru
herp
simplex
viru
hsv
scrapi
prion
unidentifi
msassoci
agent
parainfluenza
viru
measl
viru
simian
viru
chimpanze
cytomegaloviru
coronaviru
ebv
unidentifi
smonlik
viru
subacut
myeloopticoneuropathi
viru
tickborn
enceph
viru
vzv
propos
mechan
direct
brain
peripher
infect
activ
autoreact
cell
nerv
myelin
bystand
activ
epitop
spread
molecular
mimicri
virusviru
interact
howev
link
ms
shown
weak
major
virus
consist
independ
confirm
studi
viral
involv
ms
ebv
appear
confirm
indirect
link
histori
infecti
mononucleosi
im
primari
infect
ebv
caus
im
high
ebv
nuclear
antigen
igg
titer
ms
onset
howev
new
concept
aros
discoveri
herv
express
pathogen
protein
diseas
best
evid
associ
pathogen
involv
hervwmsrv
detect
ms
blood
spinal
fluid
brain
parallel
ms
stage
activeremiss
phase
therapi
outcom
ebv
known
activ
hervwmsrv
vitro
vivo
im
patient
healthi
human
high
igg
titer
suggest
ebv
could
initi
trigger
hervwmsrv
direct
neuropathogen
contributor
ms
addit
known
contribut
promot
autoreact
cell
immunoinflamm
remyelin
blockad
amyotroph
later
sclerosi
al
neurodegen
diseas
character
loss
upper
lower
motor
neuron
symptom
usual
start
one
anatom
region
spread
caus
motor
paralysi
dysphagia
ultim
affect
respiratori
function
case
al
also
involv
prefront
lobe
lead
cognit
dysfunct
vast
major
case
sporad
patient
genet
abnorm
associ
famili
form
al
chronic
inflammatori
demyelin
polyneuropathi
cidp
peripher
nervou
system
diseas
commonest
chronic
immunemedi
peripher
neuropathi
take
either
relaps
progress
cours
clinic
manifest
develop
weak
sensori
disturb
lead
mark
disabl
multifoc
inflamm
strip
myelin
sheath
macrophag
thought
result
aberr
immun
respons
mediat
andor
b
lymphocyt
peripher
nerv
antigen
human
endogen
retrovirus
herv
sequenc
belong
human
erv
famili
retain
structur
featur
retrovir
genom
becom
integr
genom
repeat
infect
evolut
immun
toler
unrespons
immun
system
substanc
normal
elicit
immun
respons
major
histocompat
complex
mhc
cellsurfac
protein
crucial
recognit
foreign
molecul
immun
system
bind
antigen
deriv
pathogen
display
recognit
appropri
cell
mobil
genet
element
repres
nearli
human
genom
consist
retrotransposon
dna
transposon
myelin
major
compon
white
matter
consist
lipidrich
structur
organ
multilay
sheath
around
axon
provid
axon
integr
trophic
metabol
support
acceler
reduct
antienv
antibodi
reactiv
hervh
hervw
msassoci
retroviru
msrv
load
blood
seen
ms
patient
treat
ifnb
suggest
efficaci
therapi
low
diseas
activ
initi
studi
first
present
evid
herpesvirus
might
trigger
herv
patient
ms
part
retroviru
hypothesi
ms
etiolog
sever
team
show
transcript
herv
gene
andor
revers
transcriptas
rt
activ
increas
variou
human
cell
vitro
herpesvirida
tropism
nervou
cell
includ
herp
simplex
viru
type
lymphocyt
ms
patient
sequenc
repres
remnant
mobil
genet
machineri
repres
nearli
human
genom
predominantli
retrotransposon
use
rna
intermedi
copypast
mechan
retrointegr
chromosom
dna
transposon
use
cut
past
mechan
repres
human
genom
respect
among
retrotransposon
import
group
repres
endogen
retrovirus
erv
herv
human
erv
enter
genom
speci
infect
germlin
cell
evolut
lead
subsequ
endogenizationintegr
genom
presenc
dna
everi
cell
offspr
human
genom
constitut
herv
sequenc
complet
sequenc
reveal
intact
code
sequenc
function
herv
protein
repres
remain
sequenc
compris
noncod
dna
often
within
intron
classic
gene
potenti
role
gener
noncod
rna
b
endogen
herv
dna
sequenc
often
truncat
contain
mutat
insert
delet
complet
copi
also
present
gag
groupspecif
antigen
pol
polymeras
env
envelop
gene
encod
structur
protein
flank
two
invert
repeat
noncod
region
compris
mani
regulatori
function
promot
enhanc
primerbind
site
revers
transcript
other
virus
report
transactiv
herv
exogen
retrovirus
specif
tax
transactiv
potent
increas
transcript
activ
hervw
hervh
hervk
herv
famili
cell
moreov
effect
hiv
hervk
hervw
astrocyt
cell
line
peripher
blood
cell
vitro
report
mediat
hiv
tat
protein
indirectli
activ
hervw
tolllik
along
tnfa
nfkb
thu
pathway
hiv
tat
could
influenc
non
hivinfect
cell
indirect
mechan
suggest
hivdriven
activ
pathway
requir
persist
tat
stimul
herv
activ
differ
herpesvirida
selfsustain
herv
express
may
induc
follow
specif
trigger
event
could
explain
lifelong
progress
ms
multipl
trigger
event
requir
pathogen
threshold
lead
diseas
onset
pass
nonetheless
herv
protein
express
herv
rna
express
transcript
alon
seem
biolog
effect
per
se
human
moreov
produc
herv
protein
implicitli
pathogen
exampl
provid
gag
groupspecif
antigen
encod
capsid
protein
hervw
immunopathogen
effect
peripher
blood
lymphocyt
cultur
healthi
donor
wherea
env
protein
hervw
particl
previous
term
msrv
induc
proinflammatori
superantigen
sag
like
effect
abnorm
activ
herv
thought
proinflammatori
effect
lead
dysregul
immun
system
illustr
relev
exampl
hervk
hervw
famili
share
interest
common
featur
protein
encod
env
gene
shown
trigger
respons
lymphocyt
cell
express
specif
variabl
region
cell
receptor
tcr
b
chain
vitro
usual
lymphocyt
recogn
target
antigen
combin
variabl
domain
tcr
chain
defin
antigenbind
site
specif
cell
clone
interact
herv
env
protein
anoth
tcr
region
known
independ
antigenbind
site
present
numer
cell
known
activ
multipl
clone
irrespect
antigen
specif
molecul
induc
polyclon
activ
sag
inflammatori
loop
also
like
contribut
herv
pathogen
follow
initi
prime
induct
specif
herv
copi
macrophag
andor
b
cell
produc
herv
env
protein
might
fuel
local
innat
inflamm
upregul
major
histocompat
complex
nerv
conduct
structur
integr
vital
import
cn
function
neuroregener
substanti
differ
extent
cellular
origin
neuroregen
respons
cn
peripher
nervou
system
pn
wherea
injur
axon
lost
myelin
sheath
restor
injur
peripher
nerv
repair
process
cn
scarc
limit
partial
remyelin
demyelin
cn
axon
function
impair
highli
vulner
degener
time
contrast
peripher
neuron
injur
central
neuron
lack
capac
regrow
axon
contribut
irrevers
function
deficit
nonetheless
chronic
pn
diseas
cidp
extent
repair
function
recoveri
also
larg
impair
ms
inflammatori
diseas
central
nervou
system
cn
major
caus
neurolog
impair
young
adult
avail
cure
ms
current
therapi
limit
number
relaps
slow
diseas
progress
common
symptom
includ
chronic
fatigu
paresthesia
acut
chronic
pain
optic
neuriti
paresi
gait
disturb
incoordin
sphincter
problem
cognit
impair
altogeth
lead
progress
disabl
histopatholog
ms
character
demyelin
lesion
predominantli
expand
white
matter
caus
destruct
myelin
oligodendrocyt
lead
axon
disrupt
brain
spinal
figur
success
step
lead
endogen
retrovirus
multicopi
endogen
retrovir
erv
famili
descend
illustr
depict
success
step
retrovir
endogen
start
infect
gamet
integr
dna
retrovir
copi
proviru
chromosom
give
birth
viabl
individu
inherit
retain
copi
dna
cell
transmit
offspr
throughout
success
gener
evolut
endogen
retrotransposit
reinfect
germlin
particular
individu
provid
exogen
strain
persist
environ
gener
multipl
variabl
copi
number
final
popul
variabl
well
known
anim
speci
recent
also
evidenc
human
abbrevi
env
envelop
gag
groupspecif
antigen
ltr
long
termin
repeat
pol
polymeras
wherea
initi
diseas
stage
may
present
revers
phase
remiss
follow
relaps
evolut
toward
progress
form
gener
follow
relaps
form
domin
aberr
inflammatori
respons
wherea
progress
stage
neurodegen
featur
take
preced
may
parallel
repeat
abnorm
lymphocyt
stimul
known
lead
cell
exhaust
anergi
deplet
implicitli
downregul
celldriven
activ
b
cell
underli
etiolog
ms
still
fulli
understood
multipl
diseaseassoci
loci
confer
genet
predisposit
develop
ms
numer
environment
factor
eg
infecti
mononucleosi
smoke
appear
contribut
diseas
onset
progress
led
formul
pathogen
concept
base
geneenviron
interact
partial
elus
role
viral
infect
search
etiolog
factor
ms
herv
detect
within
human
genom
thu
open
new
avenu
research
potenti
interact
environment
factor
divers
scientif
technic
approach
indic
three
human
endogen
retrovirus
hervh
hervk
hervw
may
abnorm
repres
express
ms
genet
polymorph
singl
copi
hervhrel
element
rel
distribut
ms
patient
except
primari
progress
form
ppm
report
hervk
mrna
express
found
upregul
postmortem
brain
tissu
ms
patient
evid
protein
express
provid
retrovir
sequenc
rtpcr
select
primer
particl
produc
ms
deriv
ebvb
lymphoblastoid
cell
line
identifi
sequenc
variant
homolog
hervh
element
formerli
name
rtvlh
rgh
anoth
studi
show
b
cell
monocyt
patient
activ
ms
show
detect
surfac
express
hervh
env
hervw
env
taken
togeth
evid
suggest
activ
multipl
herv
famili
might
link
ms
compel
evid
associ
herv
express
ms
hervw
come
recent
metaanalysi
line
research
prompt
isol
retrovir
particl
ms
patient
earli
subsequ
studi
follow
year
reveal
particl
origin
herv
element
first
term
msassoci
retroviru
msrv
whose
sequenc
determin
purifi
retroviruslik
particl
isol
ms
cell
cultur
supernat
initi
sequenc
identifi
sever
ms
isol
obtain
use
pcr
protocol
design
detect
unknown
retrovir
sequenc
flank
conserv
domain
retrovir
pol
polymeras
gene
prototyp
msrv
sequenc
identifi
previous
unknown
herv
famili
name
hervw
use
tryptophan
w
trna
primer
revers
transcript
compris
multipl
copi
homolog
msrv
prototyp
sequenc
independ
group
subsequ
report
hervw
env
pol
express
could
detect
serum
peripher
blood
mononuclear
cell
pbmc
csf
ms
patient
healthi
control
hervw
associ
ms
evidenc
studi
show
express
level
correl
ms
also
increas
diseas
activ
progress
investig
indic
herv
protein
express
mainli
restrict
macrophag
microglia
minor
proport
lymphocyt
endotheli
astrocyt
cell
activ
lesion
area
hervw
env
protein
similarli
detect
ms
lesion
use
differ
monoclon
antibodi
mab
direct
differ
epitop
associ
area
activ
demyelin
activ
chronic
brain
lesion
fairli
intens
express
death
patient
seen
postmortem
suggest
involv
longterm
pathogen
progress
diseas
hervw
reveal
play
function
role
inflammatori
process
proinflammatori
cytokin
express
shown
induc
human
murin
monocyt
upon
vitro
stimul
hervw
recombin
env
protein
process
requir
receptor
activ
msrv
envtreat
human
dendrit
cell
elicit
promot
type
helper
cell
like
lymphocyt
differenti
msrv
particl
hervw
previous
shown
induc
superantigenlik
cell
respons
reproduc
env
protein
gagencod
capsid
protein
hypothet
scenario
illustr
effect
present
figur
hervw
envelop
also
promot
eae
mous
induc
elev
autoimmun
cell
reactiv
addit
pathogen
effect
target
immun
function
hervw
env
protein
also
found
mediat
effect
nonimmun
cell
treatment
cultur
primari
oligodendrogli
precursor
cell
opc
hervw
env
shown
result
overal
reduct
oligodendrogli
differenti
via
activ
opc
contribut
neuroregener
myelin
repair
process
adult
cn
block
differenti
hervw
env
protein
may
therefor
result
remyelin
failur
figur
neg
impact
myelin
synthesi
primari
oligodendrogli
cell
could
rescu
use
specif
envneutr
human
immunoglobulin
term
differ
mab
version
assess
small
scale
msrv
envinduc
experiment
allerg
enceph
eae
anim
model
ms
appear
inhibit
somehow
revers
eae
clinic
evolut
addit
exposur
brain
endotheli
cell
line
hervw
env
shown
impair
endotheli
cell
physiolog
boost
express
allow
cell
home
tissu
proinflammatori
cytokin
releas
via
activ
therebi
suggest
env
might
affect
bbb
integr
figur
togeth
data
argu
pathogen
hervw
env
protein
formerli
msrvenv
potenti
therapeut
target
ms
neutral
human
antibodi
therefor
warrant
develop
inde
sever
earlyphas
trial
complet
phase
iib
multicent
clinic
trial
includ
relapsingremit
ms
rrm
patient
european
countri
ongo
human
antibodi
trial
year
studi
placebo
arm
three
treat
group
receiv
intraven
infus
everi
week
mgkg
clinicaltrialsgov
identifi
anoth
approach
base
hypothesi
antiretrovir
drug
effect
exogen
hiv
infect
might
also
block
herv
express
ms
led
dedic
evalu
clinicaltrialsgov
identifi
gave
neg
result
primari
endpoint
http
trial
baselineversustreat
studi
patient
activ
rrm
defin
gadoliniumenhanc
lesion
magnet
reson
imag
mri
baselin
monitor
month
monthli
mri
treat
integras
inhibitor
raltegravir
month
trial
reach
primari
endpoint
goal
significantli
reduc
either
lesion
count
lesion
develop
treatment
period
versu
baselin
nonetheless
test
drug
known
effect
inhibitor
hiv
integras
play
role
chromosom
retrointegr
newli
gener
hiv
dna
copi
may
major
aspect
herv
express
unlik
key
issu
herv
env
product
mode
action
antihiv
drug
may
relev
effect
herv
thu
explain
neg
result
studi
final
follow
studi
hervw
env
protein
detect
sera
lymphoid
cell
ms
patient
healthi
control
neurolog
diseas
except
retroviru
hervw
envelop
env
protein
activ
tolllik
receptor
opc
pathogen
hervw
env
protein
block
differenti
cell
potenti
impact
natur
occur
myelin
repair
opc
target
phervw
env
either
contact
microglia
present
phervw
env
protein
cell
membran
surfac
interact
secret
shed
phervw
env
protein
extracellular
space
cidp
case
recent
studi
confirm
upregul
hervw
express
blood
cell
peripher
nerv
lesion
patient
suffer
cidp
investig
also
show
effect
hervw
env
protein
primari
human
schwann
cell
direct
effect
schwann
cell
abil
hervw
env
protein
caus
tissu
inflamm
system
autoimmun
make
interest
potenti
new
target
treatment
patient
cidp
hervw
upregul
evid
suggest
hervw
specif
ms
may
involv
differ
diseas
pathogen
properti
env
protein
upon
activ
variabl
factor
differ
condit
tissu
organ
first
evid
retrovir
element
might
activ
al
came
studi
brain
tissu
extract
two
al
patient
guam
found
rnadirect
dna
polymeras
activ
polymeras
activ
rnasesensit
suggest
rt
activ
howev
viru
transmiss
agent
identifi
subsequ
studi
patient
al
confirm
presenc
rt
serum
although
limit
number
show
nearli
patient
detect
rt
activ
wherea
activ
detect
smaller
number
firstdegre
rel
even
smaller
number
unrel
control
howev
sever
attempt
find
exogen
retroviru
patient
al
unsuccess
detect
rt
encod
pol
gene
hervk
report
brain
patient
sporad
al
express
specif
al
protein
result
hervk
pol
activ
could
detect
brain
patient
parkinson
diseas
normal
brain
despit
occasion
detect
patient
cancer
sequenc
pol
gene
rna
transcript
suggest
activ
multipl
loci
predomin
homolog
copi
chromosom
subsequ
studi
show
express
hervk
pol
env
gag
gene
brain
patient
sporad
al
express
level
gene
correl
suggest
entir
hervk
genom
activ
hervk
env
protein
express
also
detect
cortic
spinal
neuron
al
patient
wherea
immunostain
found
brain
healthi
individu
patient
alzheim
diseas
hervk
viru
sonam
use
lysin
k
trna
primer
hervk
repres
thousand
insert
human
genom
larg
complet
provir
sequenc
identifi
date
number
insert
vari
human
popul
copi
necessarili
found
fix
chromosom
site
carrier
individu
new
insert
thought
occur
within
past
million
year
appear
modern
human
recent
endogen
hervk
element
complet
orf
form
complet
viral
particl
probabl
recent
insert
human
genom
evolut
yet
introduc
major
delet
mutat
epigenet
mechan
like
respons
hervk
gene
silenc
may
overcom
environment
trigger
given
genet
complex
remain
unknown
whether
express
hervk
patient
al
deriv
singl
copi
complet
retrovir
sequenc
might
repres
transcomplement
partial
defect
complementari
copi
scenario
may
also
relev
activ
hervw
ms
could
also
result
express
herv
pathogen
protein
hervk
also
play
role
earli
human
embryon
develop
express
morula
blastocyst
stage
preimplant
embryo
express
silenc
later
fetal
develop
howev
hervk
express
forc
neuron
caus
cellular
degener
mediat
env
protein
transgen
mice
express
hervk
env
neuron
develop
clinic
patholog
phenotyp
resembl
al
upper
lower
motor
neuron
degener
trigger
express
hervk
adult
neuron
patient
al
remain
unknown
vitro
studi
show
neuron
injuri
due
oxid
stress
excitotox
insuffici
caus
activ
hervk
gene
nonetheless
endogen
express
modul
transcript
factor
five
bind
site
hervk
ltr
known
dysregul
al
propos
biomark
al
lesion
possibl
hervk
play
crucial
role
pathophysiolog
al
repres
figur
attract
sever
reason
would
explain
sever
research
detect
rt
al
brain
blood
sampl
abl
demonstr
humantoanim
humantohuman
transmiss
diseas
herv
aris
genom
environ
may
also
explain
anatom
spread
ill
paracrin
activ
permiss
autolog
cell
gener
start
one
region
bodi
spread
along
anatom
pathway
addit
potenti
mechan
lead
new
therapeut
perspect
patient
hervk
although
endogen
retain
retrovir
properti
underli
pathogen
express
approach
drug
develop
similar
taken
hiv
could
consid
panel
antiretrovir
drug
approv
treat
hiv
infect
screen
elev
concentr
found
necessari
control
hervk
replic
hela
cell
vitro
previou
pilot
clinic
trial
indinavir
proteas
inhibitor
use
hiv
antiretrovir
therapi
fail
show
efficaci
al
notabl
patient
hiv
infect
develop
alslik
syndrom
may
show
symptom
regress
halt
evolut
treatment
antihiv
drug
patient
also
show
express
hervk
blood
level
fell
patient
initi
antiretrovir
drug
previous
discuss
context
hervw
possibl
hiv
protein
tat
may
regul
express
hervk
could
explain
trigger
pathway
express
feedback
loop
may
differ
sporad
al
associ
hiv
remain
possibl
antihiv
drug
might
inde
inhibit
hervk
efficaci
good
hiv
investig
possibl
antiretrovir
therapi
might
benefit
al
openlabel
pilot
studi
initi
australia
uk
trial
enrol
patient
al
follow
month
without
treatment
treat
month
triumeqwhich
includ
two
revers
transcriptas
inhibitor
abacavir
amivudin
shown
effect
inhibit
hervk
revers
transcriptas
activ
vitro
integras
inhibitor
dolutegravir
clinicaltrialsgov
identifi
present
review
discuss
larg
disregard
aspect
herv
multicopi
element
may
dysregul
epigenet
chang
transactiv
environment
trigger
contribut
develop
neurolog
diseas
ms
al
cidp
data
accumul
recent
decad
provid
rational
identifi
particular
herv
famili
toxic
protein
potenti
therapeut
target
diseas
alreadi
herv
evolutionarili
acquir
mostli
defect
inact
compris
epigenet
silenc
genet
element
without
assign
physiolog
function
howev
reason
maintain
repres
human
genom
herv
dynam
health
diseas
relat
transcript
activ
protein
express
composit
mutat
ancestr
copi
well
unfix
nonubiquit
copi
best
neutral
endogen
protein
encod
herv
potenti
approach
includ
vaccin
antibodymedi
neutral
pathogen
compon
antiretrovir
compound
appropri
window
opportun
antiherv
treatment
biomark
identifi
peripher
blood
would
permit
routin
assess
herv
reactiv
cn
diseas
prompt
differ
group
evalu
novel
therapeut
approach
patient
ms
al
one
potenti
strategi
reli
upon
analog
endogen
herv
ancestr
exogen
retrovir
origin
propos
test
antiretrovir
drug
effect
hivinfect
htlvinfect
patient
exampl
associ
myelopathi
anoth
strategi
may
use
human
neutral
antibodi
target
toxic
env
protein
mediat
hervw
pathogen
illustr
figur
perspect
offer
emerg
new
categori
pathogen
within
given
consist
find
interplay
epidemiolog
associ
environment
scenario
depict
hypothes
origin
retrovir
endogen
evolut
speci
million
year
ago
transmiss
herv
copi
human
hervk
copi
may
remain
dormant
latent
activ
still
unknown
mechan
figur
relat
recent
hervk
insert
previou
insert
million
year
ago
thought
activ
copi
normal
less
mutat
earlier
insert
activ
specif
area
central
nervou
system
result
pathogen
pathway
involv
hervk
express
releas
envelop
env
protein
caus
neurotox
target
motor
neuron
factor
relev
pathogen
effect
unlik
limit
exampl
discuss
present
review
although
mani
issu
remain
unresolv
see
outstand
question
scientif
domain
repres
rapidli
evolv
area
cuttingedg
research
box
studi
may
reveal
herv
contribut
complex
multifactori
human
diseas
therapeut
approach
target
toxic
herv
protein
directli
herv
gene
express
may
thu
creat
chang
paradigm
complet
novel
treatment
perspect
final
least
interest
treatment
target
nonphysiolog
herv
mul
ple
pathogen
outcom
brain
target
cell
involv
herv
express
ms
al
provid
shift
paradigm
understand
complex
pathogenesi
also
develop
therapeut
strategi
prevent
treat
diseas
although
posit
result
first
therapeut
attempt
target
herv
element
pathogen
protein
would
creat
immedi
breakthrough
emerg
domain
herv
human
diseas
like
remain
cuttingedg
scienc
mani
year
perspect
futur
research
domain
frontier
scienc
expect
unravel
etiopathogen
cascad
lead
mani
chronic
complex
multifactori
diseas
present
knowledg
remain
obscur
partial
appropri
therapeut
approach
yet
avail
